Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Alison Oliveto

Concepts (177)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Opioid-Related Disorders
20
2023
389
3.550
Why?
Cocaine-Related Disorders
20
2017
205
3.480
Why?
Methadone
15
2023
179
2.330
Why?
Sertraline
3
2017
46
1.390
Why?
Naloxone
5
2013
79
1.340
Why?
Narcotic Antagonists
9
2013
135
1.260
Why?
Buprenorphine
10
2023
146
1.140
Why?
Substance Withdrawal Syndrome
6
2021
167
1.100
Why?
Analgesics, Opioid
7
2023
568
0.990
Why?
Cyclohexanecarboxylic Acids
3
2014
18
0.950
Why?
Amines
3
2014
39
0.950
Why?
gamma-Aminobutyric Acid
3
2014
63
0.930
Why?
Methadyl Acetate
3
2010
11
0.910
Why?
Opiate Substitution Treatment
4
2023
95
0.870
Why?
Double-Blind Method
20
2021
682
0.870
Why?
Narcotics
10
2008
107
0.860
Why?
Amphetamine-Related Disorders
3
2021
93
0.820
Why?
Disulfiram
2
2013
10
0.800
Why?
Video Games
1
2022
13
0.790
Why?
Methamphetamine
3
2021
195
0.760
Why?
Adult
35
2021
13568
0.730
Why?
Prescription Drug Misuse
1
2019
33
0.630
Why?
Drug Monitoring
1
2019
78
0.630
Why?
Dose-Response Relationship, Drug
10
2013
1356
0.610
Why?
Depression
2
2014
572
0.590
Why?
Dopamine Uptake Inhibitors
3
2007
55
0.570
Why?
Male
33
2021
25718
0.530
Why?
Middle Aged
21
2021
12460
0.520
Why?
Databases, Factual
1
2019
667
0.520
Why?
Cocaine
6
2017
172
0.510
Why?
Remote Consultation
1
2015
29
0.510
Why?
Female
32
2021
26981
0.500
Why?
Neurology
1
2015
36
0.500
Why?
Desipramine
6
2005
26
0.470
Why?
Humans
45
2023
50389
0.460
Why?
Isradipine
2
2004
5
0.450
Why?
Rural Health Services
1
2015
168
0.440
Why?
Alcohol Deterrents
1
2013
8
0.430
Why?
Diltiazem
1
2013
10
0.430
Why?
Excitatory Amino Acid Antagonists
1
2013
50
0.430
Why?
Verapamil
1
2013
22
0.430
Why?
Emergency Service, Hospital
4
2021
482
0.430
Why?
Calcium Channel Blockers
1
2013
64
0.410
Why?
Electrocardiography
1
2013
267
0.380
Why?
Behavior Therapy
2
2010
180
0.360
Why?
Sodium Oxybate
1
2010
11
0.350
Why?
Pilot Projects
8
2021
704
0.350
Why?
Behavior
1
2010
47
0.350
Why?
Bupropion
2
2007
34
0.350
Why?
Hypnotics and Sedatives
1
2010
74
0.340
Why?
Combined Modality Therapy
5
2017
641
0.330
Why?
Benzhydryl Compounds
1
2009
67
0.320
Why?
Citalopram
1
2007
17
0.280
Why?
Drug Therapy, Combination
5
2014
383
0.280
Why?
Feedback
2
2023
52
0.250
Why?
Adrenergic Uptake Inhibitors
1
2005
15
0.240
Why?
Stress Disorders, Post-Traumatic
1
2010
377
0.240
Why?
Dextromethorphan
1
2004
16
0.230
Why?
Antidepressive Agents, Tricyclic
5
2004
27
0.230
Why?
Discrimination Learning
1
2004
61
0.220
Why?
Cycloserine
1
2003
3
0.220
Why?
Antimetabolites
1
2003
12
0.220
Why?
Behavior Control
1
2003
3
0.220
Why?
Diagnosis, Dual (Psychiatry)
3
2014
41
0.210
Why?
Tai Ji
1
2023
22
0.210
Why?
Naltrexone
1
2003
59
0.210
Why?
Behavior, Addictive
1
2003
57
0.210
Why?
Young Adult
5
2021
4064
0.200
Why?
Secondary Prevention
2
2013
79
0.200
Why?
Nalbuphine
1
2002
2
0.200
Why?
Butorphanol
1
2002
6
0.200
Why?
Dextroamphetamine
1
2021
39
0.190
Why?
Emotions
1
2023
166
0.190
Why?
Prospective Studies
3
2019
2414
0.190
Why?
Treatment Outcome
9
2017
5230
0.190
Why?
Heroin Dependence
4
2006
44
0.180
Why?
Placebos
4
2011
84
0.180
Why?
GABA Agonists
2
2014
14
0.180
Why?
Predictive Value of Tests
2
2019
934
0.180
Why?
Patient Compliance
2
2014
231
0.180
Why?
Self Report
2
2013
203
0.180
Why?
Chromatography, High Pressure Liquid
1
2021
326
0.170
Why?
Guideline Adherence
1
2021
133
0.170
Why?
Psychomotor Agitation
1
2020
50
0.170
Why?
Adolescent
3
2022
6475
0.170
Why?
Tandem Mass Spectrometry
1
2021
237
0.170
Why?
Blood Pressure
3
2011
529
0.170
Why?
Central Nervous System Stimulants
1
2021
205
0.160
Why?
Severity of Illness Index
2
2013
963
0.160
Why?
Retrospective Studies
4
2022
6223
0.150
Why?
Antipsychotic Agents
1
2020
230
0.150
Why?
Ambulatory Care
3
2011
228
0.150
Why?
Risk Assessment
2
2020
1258
0.150
Why?
Effect Modifier, Epidemiologic
1
2017
7
0.150
Why?
Pain Management
1
2019
172
0.150
Why?
Area Under Curve
2
2010
179
0.140
Why?
Chronic Pain
1
2019
174
0.130
Why?
Analysis of Variance
5
2004
562
0.130
Why?
Heart Rate
2
2011
311
0.130
Why?
Mass Screening
1
2019
348
0.130
Why?
Transportation
1
2015
31
0.130
Why?
Psychiatric Status Rating Scales
4
2011
322
0.130
Why?
Time Factors
3
2011
2934
0.130
Why?
Travel
1
2015
37
0.130
Why?
Nipecotic Acids
2
2006
2
0.120
Why?
Diagnostic and Statistical Manual of Mental Disorders
2
2013
74
0.120
Why?
Cognition
2
2023
314
0.120
Why?
Tissue Plasminogen Activator
1
2015
110
0.120
Why?
Anxiety
2
2022
278
0.120
Why?
Recurrence
2
2014
664
0.110
Why?
Directly Observed Therapy
1
2013
7
0.110
Why?
Socioeconomic Factors
1
2015
590
0.110
Why?
Maintenance Chemotherapy
1
2013
49
0.110
Why?
Patient Dropouts
1
2013
51
0.110
Why?
Induction Chemotherapy
1
2013
60
0.110
Why?
Calcium Channels, L-Type
1
2013
68
0.100
Why?
Medication Adherence
1
2014
129
0.100
Why?
Drug Interactions
1
2013
208
0.100
Why?
Depressive Disorder, Major
2
2004
150
0.100
Why?
Injections, Intramuscular
2
2020
51
0.100
Why?
Substance Abuse Treatment Centers
1
2011
79
0.090
Why?
Affect
1
2011
98
0.090
Why?
Confusion
1
2010
19
0.090
Why?
Kaplan-Meier Estimate
1
2011
466
0.090
Why?
Respiration
1
2010
100
0.090
Why?
Arkansas
1
2015
1991
0.080
Why?
Psychomotor Performance
1
2010
123
0.080
Why?
Sleep
1
2011
180
0.080
Why?
Hemodynamics
1
2010
266
0.080
Why?
Alcohol Drinking
1
2010
227
0.080
Why?
Connecticut
2
2005
15
0.080
Why?
Progestins
1
2007
10
0.070
Why?
Progesterone
1
2007
59
0.070
Why?
Substance Abuse Detection
2
2006
89
0.070
Why?
Sex Characteristics
1
2008
198
0.070
Why?
Anti-Anxiety Agents
1
2006
34
0.070
Why?
Anxiety Disorders
1
2007
125
0.070
Why?
Cues
1
2006
48
0.060
Why?
Urinalysis
1
2005
32
0.060
Why?
Depressive Disorder
1
2007
336
0.060
Why?
Linear Models
2
2021
279
0.060
Why?
GABA Agents
1
2003
3
0.060
Why?
Token Economy
1
2003
33
0.050
Why?
Prefrontal Cortex
1
2023
83
0.050
Why?
Prognosis
2
2005
1979
0.050
Why?
Tobacco Use Disorder
1
2004
170
0.050
Why?
Pain Measurement
1
2003
248
0.050
Why?
Ketoconazole
1
2002
17
0.050
Why?
Limit of Detection
1
2021
15
0.050
Why?
Reproducibility of Results
2
2021
1201
0.050
Why?
Outpatients
1
2022
115
0.050
Why?
Controlled Clinical Trials as Topic
1
2020
21
0.040
Why?
Pain
1
2023
374
0.040
Why?
Magnetic Resonance Imaging
2
2023
1534
0.040
Why?
Clinical Trials as Topic
1
2002
465
0.040
Why?
California
1
2019
87
0.040
Why?
Ambulatory Care Facilities
1
2019
121
0.040
Why?
Practice Guidelines as Topic
1
2021
460
0.040
Why?
Brain
1
2006
1313
0.040
Why?
Randomized Controlled Trials as Topic
1
2020
556
0.040
Why?
Drug Administration Schedule
2
2006
369
0.030
Why?
Adrenergic alpha-2 Receptor Agonists
2
2004
9
0.030
Why?
Aged
3
2019
9590
0.030
Why?
Comorbidity
2
2006
617
0.030
Why?
Echo-Planar Imaging
1
2006
11
0.020
Why?
Photic Stimulation
1
2006
59
0.020
Why?
Reward
1
2006
114
0.020
Why?
Interview, Psychological
1
2004
23
0.010
Why?
Cerebral Cortex
1
2006
195
0.010
Why?
Receptors, Opioid, mu
1
2004
46
0.010
Why?
Psychometrics
1
2004
228
0.010
Why?
Oxygen
1
2006
321
0.010
Why?
Receptors, Opioid
1
2002
18
0.010
Why?
Chi-Square Distribution
1
2002
280
0.010
Why?
Cross-Over Studies
1
2002
224
0.010
Why?
Proportional Hazards Models
1
2002
418
0.010
Why?
Antifungal Agents
1
2002
342
0.010
Why?
Oliveto's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description